Regenerative treatments target the immune imbalance at the root of autoimmune disease, without shutting down your entire immune system the way conventional drugs do.
Autoimmune disease happens when the immune system mistakes your own tissue for a threat and attacks it. Immune cells that should be controlled escape regulation and produce inflammatory signals that damage your body over time. Depending on which tissues are targeted, this can affect the joints, organs, nervous system, skin, and connective tissue, sometimes all at once.
Standard treatments like DMARDs, biologic drugs, and corticosteroids work by suppressing immune activity to reduce inflammation and slow damage. These can help, but they come with real trade-offs: higher infection risk, organ stress with long-term use, and no way to fix the root immune dysfunction. Many patients achieve only partial relief and remain dependent on medication indefinitely.
Regenerative medicine takes a different approach. Instead of suppressing your immune system, mesenchymal stem cell (MSC) therapy aims to rebalance it. MSCs send signals that increase your body's own immune regulators and reduce the overactive immune cells causing damage. The goal is not to turn off your immune system, but to reset it so it stops attacking your own tissue.
Current research supports MSC and exosome therapies for several autoimmune conditions. Treatment approaches are tailored to each condition.
Rheumatoid arthritis causes immune-driven joint inflammation and progressive joint damage. MSCs travel to inflamed joint tissue, reduce the inflammatory signals driving the disease, and boost immune regulators that help protect cartilage and bone.
Lupus involves out-of-control immune activation that can affect many organ systems at once. MSC signaling has been shown to restore immune balance, reduce harmful autoantibodies, and calm inflammation across affected organs. Early clinical studies show reductions in disease activity scores.
Fibromyalgia and chronic inflammatory fatigue involve heightened nerve sensitivity, brain inflammation, and ongoing immune activation. Exosome-based therapies deliver anti-inflammatory signals that help calm these processes, offering a targeted approach where standard treatments often fall short.
Ankylosing spondylitis causes long-term inflammation in the spine and sacroiliac joints, which can lead to the joints fusing together over time. Regenerative protocols aim to reduce this spinal inflammation, slow structural damage, and help you move better.
A personalized plan built around a thorough assessment of your condition, disease activity, and goals.
We review your diagnosis, disease history, lab results including inflammatory markers, and current medications. This baseline helps us measure your disease activity and identify the best regenerative approach for your condition.
Based on your assessment, we design a customized plan using MSC therapy, exosome therapy, or a combination. The plan takes into account your condition, current disease activity, how you have responded to past treatments, and which parts of the immune system are most involved.
Depending on your condition, treatment is delivered by IV infusion for systemic conditions or by targeted injection for joint and spinal disease. Both are outpatient procedures. All cell and exosome preparations come from screened, certified providers.
We track your progress using repeat lab tests, disease activity scores, and how you feel day to day over a 3 to 6 month follow-up period. We encourage ongoing coordination with your existing rheumatologist or specialist throughout this time.
Immune rebalancing happens gradually. This timeline reflects what most patients experience based on clinical observations and published research.
MSCs and exosomes begin shifting the body's inflammatory balance. Some patients notice early reductions in joint pain, fatigue, or other symptoms as inflammatory signals start to decrease.
Lab tests often show measurable decreases in inflammation during this period. Disease activity scores begin to improve, and patients often report fewer flare-ups and better tolerance for daily activities.
The immune system continues to rebalance. Functional gains, including better mobility, less pain, and improved energy, typically become most noticeable during this phase.
For those who respond well, benefits hold and may keep improving. Some patients are able to reduce their medication load in coordination with their doctor. This is one of the main goals of the regenerative approach.
Talk with our clinical team to find out if regenerative therapy is right for your autoimmune condition and goals.
Book Your Consultation →